Tag: Ki67

OptraSCAN Digital Pathology Launches On-Demand Image Analysis Suite at USCAP 2017

| March 6, 2017 | 0 Comments

Affordable and scanner agnostic image analysis solutions utilizing artificial intelligence for colorimetric and morphometric analysis for oncology, neuroscience and toxicological pathology SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN, Inc. today announced the launch of its next generation, On-Demand suite of image analysis software for digital pathology, which includes OptraASSAYSTM, CARDSTM and OptraPROCESSTM. The image analysis suite supports both individual, […]

Continue Reading

Will Not Using Image Analysis in Pathology be Perceived as Irresponsible? 

| February 1, 2017 | 0 Comments

Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com.  It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More quantitative analysis. Better, faster, cheaper, more accurate. Image analysis and tele-consultation have been and will […]

Continue Reading

OptraSCAN Announces the Availability of a Breast Cancer-Focused Panel of Algorithmic Biomarkers as Part of its On-Demand Model

| July 14, 2016 | 0 Comments

OptraSCANTM On-Demand Digital Pathology announced today the availability of a Breast Cancer Focused Panel of Algorithmic Biomarkers (ER/PR, HER-2/neu, Ki67, P53, EGFR, AE1/AE3) through its OptraASSAYSTM and OptraCARDSTM Solutions, as part of its subscription-based model (starting at $1,950 per month for a six-month commitment, which includes: the OptraSCAN Scanner, Data Storage, TELEPath Telepathology and Service). […]

Continue Reading

Join Omnyx for a Webinar!

| April 10, 2016 | 0 Comments

Quantification Algorithms: Value and Progress in Standardization of IHC Breast Tissue Data April 13th, 2016 12:00 PM EST Michael Grunkin, Ph.D. Chief Executive Officer Visiopharm In collaboration with Visiopharm®, Dynamyx™ software provides pathologists sophisticated tools that incorporate precision, quantification and confidence in decision-making for breast panel analysis (HER2, ER, PR, Ki67). These algorithms give pathologists […]

Continue Reading

Applied Spectral Imaging received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67

| April 16, 2015 | 0 Comments

Carlsbad, CA. – April 16, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the South Korean Ministry of Food and Drug Safety (MFDS) for its GenASIs HiPath image capture and analysis platform. The South Korean market is a key market for ASI’s computer-aided imaging solutions for pathology, which […]

Continue Reading

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope

| July 25, 2014 | 0 Comments

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope A complete solution for FISH, CISH and IHC Applied Spectral Imaging Inc. develops computer aided image analysis & diagnostic tools for clinical and research applications. The GenASIs platform integrates within the existing workflow of the microscope, pathologist and LIS framework, […]

Continue Reading